Austria, Austria

Tobias Wunberg

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tobias Wunberg. Retrieved from https://idiyas.com/inventor/tobias-wunberg-w2m3dr9c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tobias Wunberg

Introduction

Tobias Wunberg is a notable inventor based in Österreich, AT. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on aryl-substituted heterocycles. His research focuses on the treatment and prophylaxis of various diseases, showcasing his commitment to advancing medical science.

Latest Patents

Wunberg holds a patent for "Aryl-substituted heterocycles, and use thereof." This invention relates to the preparation of aryl-substituted heterocycles and their application in developing medicaments for treating thromboembolic disorders. His work in this area highlights the potential for new therapeutic approaches in medicine.

Career Highlights

Tobias Wunberg is associated with Bayer Intellectual Property GmbH, where he continues to innovate and contribute to the pharmaceutical industry. His role at Bayer allows him to collaborate with other experts in the field and push the boundaries of current medical treatments.

Collaborations

Some of his notable coworkers include Michael Härter and Swen Allerheiligen. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical sector.

Conclusion

Tobias Wunberg's work exemplifies the impact of innovative thinking in medicine. His contributions through patents and collaborations are paving the way for new treatments and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…